DIA 2020 Virtual Global Annual Meeting has ended

Create Your Own Event

DIA 2020 Virtual Global Annual Meeting

arrow_back View All Dates

8:00am EDT

#201 L: Patient-Centricity: How do We Measure Progress in Involving Patients in Drug Development and Drug Safety? TBD #202 L: Novel Approaches to Study Prevalent Chronic Diseases as Alternatives to Large-Scale Clinical Trials TBD #203 L: ICH 30th Anniversary Series: The Role of Multidisciplinary Topics TBD #204 L: Implementing Quality by Design for Clinical Trials: New Tools, Case Studies, and Multi-Stakeholder Discussion TBD #205 SL: Using Artificial Intelligence to Inform Regulatory and Development Strategies TBD #206 L: Regulatory Agility During the COVID-19 Pandemic TBD

9:30am EDT

#209 L: Data Driven Monitoring Enabled Through Analytics and Quality Risk Management TBD #211 L: Balancing Clinical Trial Disclosure and Transparency With Global Data Protection Regulations TBD #212 L: Qualitative, Quantitative, and Mixed Method Approaches to Capture the Patient Experience TBD #214 L: GCP Quality and Compliance: The Regulators’ Perspective TBD

11:30am EDT

#220 L: Disruptive Transformation in Safety Organizations TBD #221 L: Non-Traditional Clinical Trials Require a Non-Traditional Workforce TBD #222 L: Patient-Centricity: How Do We Talk to and Listen to Patients? TBD #223 L: Next Generation Analytics: Harnessing the Power of Nonclinical SEND Datasets to Improve Success in Early Clinical Development TBD #224 SL: Sponsor and Regulator Challenges, Risks, and Mitigation Strategies for Ensuring Third-Party Oversight of Vendors: Is Your Study Data at Risk? TBD

2:00pm EDT

#234 SL: Practical Solutions for Designing and Conducting a Digital Health Trial TBD #235 SL: Examining Diversity in Clinical Trials TBD #236 L: FDA Data Standards Update TBD #237 L: Patient Voice and Its Role In Bringing Meaningfulness into Selection of Clinical Outcome Measures TBD #238 SL: Utilizing Cloud-Based Platforms in Regulatory Contexts TBD #239 L: The FDA Complex Innovative Trial Design Pilot Program: Case Examples TBD

4:00pm EDT

#246 SL: FDA Pre-Market Safety Assessment Program TBD #248 L: Incorporating the Patient Perspective in a Drug Development Program TBD